[
  {
    "date": "2023-12-30",
    "symbol": "IKNA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "entityregistrantname": "IKENA ONCOLOGY, INC.",
    "entitycentralindexkey": 1835579,
    "entityincorporationstatecountrycode": "DE",
    "entityfilenumber": "001-40287",
    "entitytaxidentificationnumber": "81-1697316",
    "entityaddressaddressline1": "645 Summer Street",
    "entityaddressaddressline2": "Suite 101",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2210,
    "cityareacode": 857,
    "localphonenumber": "273-8343",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "IKNA",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 119894000,
    "marketablesecuritiescurrent": 55571000,
    "prepaidexpenseandotherassetscurrent": 3197000,
    "assetscurrent": 178662000,
    "propertyplantandequipmentnet": 2335000,
    "operatingleaserightofuseasset": 5686000,
    "depositsandotherassetsnoncurrent": 5409000,
    "assets": 192092000,
    "accountspayablecurrent": 2066000,
    "accruedliabilitiesandotherliabilitiescurrent": 8581000,
    "operatingleaseliabilitycurrent": 3558000,
    "liabilitiescurrent": 14205000,
    "operatingleaseliabilitynoncurrent": 7180000,
    "otherlongtermdebtnoncurrent": 950000,
    "liabilities": 22335000,
    "commonstockvalue": 48000,
    "additionalpaidincapital": 452142000,
    "accumulatedothercomprehensiveincomelossnetoftax": -48000,
    "retainedearningsaccumulateddeficit": -282385000,
    "stockholdersequity": 169757000,
    "liabilitiesandstockholdersequity": 192092000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 48258111,
    "commonstocksharesoutstanding": 48258111,
    "revenuefromcontractwithcustomerexcludingassessedtax": 9160000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://fasb.org/us-gaap/2023#InProcessResearchAndDevelopmentMember",
    "researchanddevelopmentexpense": 59652000,
    "generalandadministrativeexpense": 24925000,
    "operatingexpenses": 84577000,
    "operatingincomeloss": -75417000,
    "investmentincomeinterest": 7111000,
    "othernonoperatingexpense": 22000,
    "othernonoperatingincomeexpense": 7089000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -68328000,
    "incometaxexpensebenefit": -162000,
    "netincomeloss": -68166000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 715000,
    "comprehensiveincomenetoftax": -67451000,
    "earningspersharebasic": -1.63,
    "earningspersharediluted": -1.63,
    "weightedaveragenumberofsharesoutstandingbasic": 41735081,
    "weightedaveragenumberofdilutedsharesoutstanding": 41735081,
    "sharesoutstanding": 48258111,
    "stockissuedduringperiodvaluenewissues": 6000,
    "stockissuedduringperiodsharesnewissues": 6110000,
    "stockrepurchasedduringperiodvalue": 663000,
    "stockrepurchasedduringperiodshares": 97500,
    "temporaryequitystockissuedduringperiodvalueacquisitions": 32545000,
    "temporaryequitystockissuedduringperiodsharesacquisitions": 4153439,
    "conversionofstockamountconverted1": -31886000,
    "conversionofstocksharesconverted1": -4153439,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 4000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 4153439,
    "stockissuedduringperiodvalueacquisitions": 2000,
    "stockissuedduringperiodsharesacquisitions": 1800652,
    "temporaryequitycashconsiderationpaidtosettlerestrictedstockunitsstockoptionsandunaccreditedstockholders": 659000,
    "adjustmentstoadditionalpaidincapitalcashconsiderationpaid": 285000,
    "stockissuedduringperiodvaluestockoptionsexercised": 136000,
    "stockissuedduringperiodsharesstockoptionsexercised": 34027,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7632000,
    "othercomprehensiveincomelossnetoftax": 715000,
    "paymentsofstockissuancecosts": 2600000,
    "profitloss": -68166000,
    "depreciation": 1020000,
    "amortizationofmarketablesecurities": -2023000,
    "sharebasedcompensation": 7632000,
    "operatingleaseexpense": 1714000,
    "gainlossonsaleofproperties": -5000,
    "operatingleaseimpairmentloss": 1744000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1835000,
    "increasedecreaseinaccountspayable": -2870000,
    "increasedecreaseinaccruedliabilities": -7660000,
    "increasedecreaseinleasingreceivables": 2087000,
    "increasedecreaseincontractwithcustomerliability": -9160000,
    "increasedecreaseindepositotherassets": 1824000,
    "increasedecreaseinothernoncurrentliabilities": 97000,
    "netcashprovidedbyusedinoperatingactivities": -79743000,
    "paymentstoacquirepropertyplantandequipment": 414000,
    "paymentstoacquiremarketablesecurities": 90052000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 154610000,
    "netcashprovidedbyusedininvestingactivities": 64144000,
    "cashandcashequivalentsacquiredfromacquisitionnetofissuancecostspaid": 40030000,
    "cashconsiderationpaymentstoacquirebusiness": 944000,
    "proceedsfromissuanceofcommonstockforunderwrittenregisteredofferingnetofofferingcosts": 37421000,
    "paymentsforrepurchaseofcommonstock": 663000,
    "proceedsfromstockoptionsexercised": 136000,
    "netcashprovidedbyusedinfinancingactivities": 75980000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 60381000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 121172000,
    "restrictedcashandcashequivalentsnoncurrent": 1278000,
    "rightofuseassetrecognizeduponassumptionoflease": 3889000,
    "cashcashequivalentsandshortterminvestments": 175500000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 1300000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember",
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionexplanation": "Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.",
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "P12M",
    "cashandcashequivalentsfairvaluedisclosure": 53613000,
    "investmentsfairvaluedisclosure": 55571000,
    "assetsfairvaluedisclosure": 109184000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 55624000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 27000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 80000,
    "availableforsalesecuritiesdebtsecurities": 55571000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 23,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongernumberofpositions": 4,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongeraccumulatedloss": 22500,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 22233000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsfairvalue": 33338000,
    "clinicalmanufacturingandscientificdevelopmentcurrent": 1482000,
    "prepaidinsurance": 565000,
    "otherassetscurrent": 1150000,
    "propertyplantandequipmentgross": 2988000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2737000,
    "depreciationincludingaccelerateddepreciationondisposalofpropertyplantandequipment": 1000000,
    "employeerelatedliabilitiescurrent": 3311000,
    "accruedresearchanddevelopmentexpensescurrent": 3964000,
    "accruedprofessionalfeescurrent": 1221000,
    "otherliabilitiescurrent": 85000,
    "contractwithcustomerliabilityrevenuerecognized": 9200000,
    "commonstockvotingrights": "The holders of shares of common stock are entitled to one vote for each share of common stock held at all meetings of stockholders and written action in lieu of meetings; there is no cumulative voting. The holders of outstanding shares of common stock shall be entitled to elect two directors of the Company.",
    "commonstockcapitalsharesreservedforfutureissuance": 3413255,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "stockoptioncontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.34,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 11200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 346613,
    "increaseinnumberofsharesreservedandavailableforissuanceaspercentageoncommonstockoutstanding": 0.01,
    "allocatedsharebasedcompensationexpense": 3937000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7088261,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1750224,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1217415,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7088261,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4032553,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.35,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.01,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 6.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 6.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y11M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 94000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 94000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 94000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.87,
    "definedcontributionplanemployerdiscretionarycontributionamount": 500000,
    "currentfederaltaxexpensebenefit": -237000,
    "currentstateandlocaltaxexpensebenefit": 68000,
    "currentincometaxexpensebenefit": -169000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.064,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.012,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.006,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.042,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.3,
    "effectiveincometaxratecontinuingoperations": 0.002,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 29529000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 8581000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 14589000,
    "deferredtaxassetscapitallosscarryforwards": 196000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 802000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2381000,
    "deferredtaxassetsleaseliability": 2934000,
    "deferredtaxassetscapitalizedresearchandexperimental": 44366000,
    "deferredtaxassetsgross": 103378000,
    "deferredtaxliabilitiespropertyplantandequipment": 603000,
    "deferredtaxliabilitiesleasingarrangements": 1554000,
    "deferredincometaxliabilities": 2157000,
    "deferredtaxassetsliabilitiesnet": 101221000,
    "deferredtaxassetsvaluationallowance": 101221000,
    "valuationallowancedeferredtaxassetchangeinamount": 41200000,
    "operatinglosscarryforwards": 140600000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 11700000,
    "taxcreditcarryforwardexpirationbeginmonthandyear": "2031-12",
    "taxcutjobsactresearchandexperimentalexpenditurestobecapitalizedandamortizedperiod": "P5Y",
    "opentaxyear": 2020,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 927000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 900000,
    "unrecognizedtaxbenefits": 949000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 22000,
    "royaltiesterms": "The Company will pay the University royalties as defined in the UT Austin License on any commercialized product sales related to the licensed technology in a percentage in the low single digits.",
    "licenseagreementterminationdate": "2024-03-20",
    "lesseeoperatingleaseremainingleaseterm": "P3Y",
    "operatingleaseliability": 10738000,
    "operatingleasecost": 2316000,
    "variableleasecost": 889000,
    "leasecost": 3205000,
    "operatingleasepayments": 2534000,
    "lesseeoperatingleasediscountrate": 0.078,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 3924000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4212000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 3171000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 719000,
    "lesseeoperatingleaseliabilitypaymentsdue": 12026000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1288000,
    "operatingcostsandexpenses": 100000,
    "equitymethodinvestmentownershippercentage": 0.089,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7088261
  },
  {
    "date": "2022-12-30",
    "symbol": "IKNA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "entityregistrantname": "IKENA ONCOLOGY, INC.",
    "entitycentralindexkey": 1835579,
    "entityincorporationstatecountrycode": "Delaware",
    "entityfilenumber": "001-40287",
    "entitytaxidentificationnumber": "81-1697316",
    "entityaddressaddressline1": "645 Summer Street",
    "entityaddressaddressline2": "Suite 101",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2210,
    "cityareacode": 857,
    "localphonenumber": "273-8343",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitycurrentreportingstatus": "Yes ",
    "currentfiscalyearenddate": "December 31",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "true",
    "entitywellknownseasonedissuer": "No ",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes ",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "IKNA",
    "securityexchangename": "The Nasdaq Global Market",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entitypublicfloat": 58000000,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 59919000,
    "marketablesecuritiescurrent": 97028000,
    "prepaidexpenseandotherassetscurrent": 3063000,
    "assetscurrent": 160010000,
    "propertyplantandequipmentnet": 3205000,
    "operatingleaserightofuseasset": 5255000,
    "depositsandotherassetsnoncurrent": 3789000,
    "assets": 172259000,
    "accountspayablecurrent": 2093000,
    "accruedliabilitiesandotherliabilitiescurrent": 8343000,
    "operatingleaseliabilitycurrent": 1907000,
    "contractwithcustomerliabilitycurrent": 9160000,
    "liabilitiescurrent": 21503000,
    "operatingleaseliabilitynoncurrent": 3787000,
    "liabilities": 25290000,
    "commonstockvalue": 36000,
    "additionalpaidincapital": 361915000,
    "accumulatedothercomprehensiveincomelossnetoftax": -763000,
    "retainedearningsaccumulateddeficit": -214219000,
    "stockholdersequity": -214219000,
    "liabilitiesandstockholdersequity": 172259000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 15618000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://fasb.org/us-gaap/2022#InProcessResearchAndDevelopmentMember",
    "researchanddevelopmentexpense": 64321000,
    "generalandadministrativeexpense": 22201000,
    "operatingexpenses": 86522000,
    "operatingincomeloss": -70904000,
    "investmentincomeinterest": 2149000,
    "othernonoperatingexpense": 10000,
    "othernonoperatingincomeexpense": 2139000,
    "netincomeloss": -68765000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -763000,
    "comprehensiveincomenetoftax": -69528000,
    "earningspersharebasic": -1.9,
    "earningspersharediluted": -1.9,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 1095000,
    "stockissuedduringperiodsharesstockoptionsexercised": 282459,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7525000,
    "othercomprehensiveincomelossnetoftax": 763000,
    "profitloss": -68765000,
    "depreciation": 751000,
    "amortizationofmarketablesecurities": 50000,
    "sharebasedcompensation": 7525000,
    "operatingleaseexpense": 1283000,
    "gainlossonsaleofproperties": -173000,
    "debtsecuritiesavailableforsalerealizedgainloss": -12000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1236000,
    "increasedecreaseinaccountspayable": -291000,
    "increasedecreaseinaccruedliabilities": 2230000,
    "increasedecreaseinleasingreceivables": 1292000,
    "increasedecreaseincontractwithcustomerliability": -15618000,
    "increasedecreaseindepositotherassets": 1403000,
    "netcashprovidedbyusedinoperatingactivities": -74109000,
    "paymentstoacquirepropertyplantandequipment": 1431000,
    "paymentstoacquiremarketablesecurities": 216338000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 118485000,
    "netcashprovidedbyusedininvestingactivities": -99284000,
    "proceedsfromstockoptionsexercised": 1095000,
    "netcashprovidedbyusedinfinancingactivities": 1095000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -172298000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 60791000,
    "restrictedcashandcashequivalentsnoncurrent": 872000,
    "capitalexpendituresincurredbutnotyetpaid": 259000,
    "cashcashequivalentsandshortterminvestments": 156900000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 900000,
    "propertyplantandequipmentusefullife": "three years",
    "propertyplantandequipmentestimatedusefullives": "the shorter of their useful life or lease term.",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "accountingstandardsupdateextensiblelist": "http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201602Member",
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionexplanation": "Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. ",
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "12 months",
    "cashandcashequivalentsfairvaluedisclosure": 55861000,
    "investmentsfairvaluedisclosure": 74422000,
    "assetsfairvaluedisclosure": 97028000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 97791000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 763000,
    "availableforsalesecuritiesdebtsecurities": 97028000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 43,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 79652000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsfairvalue": 17376000,
    "clinicalmanufacturingandscientificdevelopmentcurrent": 1372000,
    "prepaidinsurance": 727000,
    "otherassetscurrent": 964000,
    "propertyplantandequipmentgross": 5030000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1825000,
    "depreciationincludingaccelerateddepreciationondisposalofpropertyplantandequipment": 900000,
    "employeerelatedliabilitiescurrent": 3236000,
    "accruedresearchanddevelopmentexpensescurrent": 4462000,
    "accruedprofessionalfeescurrent": 526000,
    "otherliabilitiescurrent": 119000,
    "contractwithcustomerliabilityrevenuerecognized": 15600000,
    "contractwithcustomerliability": 9200000,
    "commonstockvotingrights": "The holders of shares of common stock are entitled to one vote for each share of common stock held at all meetings of stockholders and written action in lieu of meetings; there is no cumulative voting. The holders of outstanding shares of common stock shall be entitled to elect two directors of the Company.",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "stockoptioncontractualterm": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 17700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 346613,
    "increaseinnumberofsharesreservedandavailableforissuanceaspercentageoncommonstockoutstanding": 0.01,
    "allocatedsharebasedcompensationexpense": 7525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 878084,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.29,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.71,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 8.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 7.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 7.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 362112000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 362112000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 358798000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0167,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0359,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.836,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.86,
    "definedcontributionplanemployerdiscretionarycontributionamount": 600000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.07200000000000001,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.005,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.006999999999999999,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.05,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.32,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 22875000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 6693000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10667000,
    "deferredtaxassetscapitallosscarryforwards": 219000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 823000,
    "deferredtaxassetsdeferredincome": 2502000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1900000,
    "deferredtaxassetsleaseliability": 1556000,
    "deferredtaxassetscapitalizedresearchandexperimental": 14995000,
    "deferredtaxassetsgross": 62230000,
    "deferredtaxliabilitiespropertyplantandequipment": 761000,
    "deferredtaxliabilitiesleasingarrangements": 1436000,
    "deferredincometaxliabilities": 2197000,
    "deferredtaxassetsliabilitiesnet": 60033000,
    "deferredtaxassetsvaluationallowance": 60033000,
    "valuationallowancedeferredtaxassetchangeinamount": 22000000,
    "operatinglosscarryforwards": 105900000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 2800000,
    "taxcreditcarryforwardexpirationbeginmonthandyear": "December 2031",
    "taxcutjobsactresearchandexperimentalexpenditurestobecapitalizedandamortizedperiod": 15,
    "opentaxyear": 2022,
    "royaltiesterms": " The Company will pay the AskAt royalties a percentage in the low single digits as defined in the AskAt License on any commercialized product sales related to the licensed technology.",
    "operatingleaseliability": 5694000,
    "operatingleasecost": 1764000,
    "variableleasecost": 466000,
    "leasecost": 2230000,
    "operatingleasepayments": 1774000,
    "lesseeoperatingleaseremainingleaseterm": 3.4,
    "lesseeoperatingleasediscountrate": 0.077,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1827000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1882000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1938000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 817000,
    "lesseeoperatingleaseliabilitypaymentsdue": 6464000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 770000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 200000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2021-12-30",
    "symbol": "IKNA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "entityregistrantname": "IKENA ONCOLOGY, INC.",
    "entitycentralindexkey": 1835579,
    "entityincorporationstatecountrycode": "Delaware",
    "entityfilenumber": "001-40287",
    "entitytaxidentificationnumber": "81-1697316",
    "entityaddressaddressline1": "645 Summer Street",
    "entityaddressaddressline2": "Suite 101",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2210,
    "cityareacode": 857,
    "localphonenumber": "273-8343",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitycurrentreportingstatus": "Yes ",
    "currentfiscalyearenddate": "December 31",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "true",
    "entitywellknownseasonedissuer": "No ",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes ",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "IKNA",
    "securityexchangename": "The Nasdaq Global Market",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 232217000,
    "prepaidexpenseandotherassetscurrent": 4299000,
    "assetscurrent": 236516000,
    "propertyplantandequipmentnet": 2439000,
    "operatingleaserightofuseasset": 6538000,
    "depositsandotherassetsnoncurrent": 2386000,
    "assets": 247879000,
    "accountspayablecurrent": 2384000,
    "accruedliabilitiesandotherliabilitiescurrent": 5854000,
    "operatingleaseliabilitycurrent": 1851000,
    "contractwithcustomerliabilitycurrent": 17100000,
    "liabilitiescurrent": 27189000,
    "operatingleaseliabilitynoncurrent": 5135000,
    "contractwithcustomerliabilitynoncurrent": 7700000,
    "liabilities": 40002000,
    "commonstockvalue": 36000,
    "additionalpaidincapital": 353295000,
    "retainedearningsaccumulateddeficit": -145454000,
    "stockholdersequity": -145454000,
    "liabilitiesandstockholdersequity": 247879000,
    "temporaryequityparorstatedvaluepershare": 0.001,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 30985000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://www.ikenaoncology.com/20211231#ResearchAndDevelopmentMember",
    "researchanddevelopmentexpense": 47108000,
    "generalandadministrativeexpense": 18015000,
    "operatingexpenses": 65123000,
    "operatingincomeloss": -34138000,
    "othernonoperatingincomeexpense": 23000,
    "netincomeloss": -34115000,
    "earningspersharebasicanddiluted": -1.22,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluenewissues": 131302000,
    "stockissuedduringperiodsharesnewissues": "null",
    "conversionofstockamountconverted1": -205979000,
    "conversionofstocksharesconverted1": "-null",
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 205979000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 582000,
    "stockissuedduringperiodsharesstockoptionsexercised": 215188,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5177000,
    "paymentsofstockissuancecosts": 2400000,
    "profitloss": -34115000,
    "depreciation": 544000,
    "sharebasedcompensation": 5177000,
    "operatingleaseexpense": 1174000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1452000,
    "increasedecreaseinaccountspayable": 361000,
    "increasedecreaseinaccruedliabilities": 1298000,
    "increasedecreaseinleasingreceivables": 740000,
    "increasedecreaseincontractwithcustomerliability": -30985000,
    "increasedecreaseindepositotherassets": 1514000,
    "netcashprovidedbyusedinoperatingactivities": -60252000,
    "paymentstoacquirepropertyplantandequipment": 1760000,
    "netcashprovidedbyusedininvestingactivities": -1760000,
    "proceedsfrompaymentforissuanceofpreferredstockandpreferencestock": -146000,
    "proceedsfrompaymentforissuanceinitialpublicoffering": 131302000,
    "proceedsfromstockoptionsexercised": 582000,
    "netcashprovidedbyusedinfinancingactivities": 131738000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 69726000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 233089000,
    "restrictedcashandcashequivalentsnoncurrent": 872000,
    "capitalexpendituresincurredbutnotyetpaid": 13000,
    "rightofuseassetsandleaseliabilitiesrecognizeduponleaseinception": 7541000,
    "stockholdersequityreversestocksplit": "one-for-7.154 reverse stock split",
    "numberofoperatingsegments": 1,
    "concentrationofcreditrisknumberoffinancialinstitutions": 2,
    "restrictedcash": 900000,
    "propertyplantandequipmentusefullife": "three years",
    "propertyplantandequipmentestimatedusefullives": "the shorter of their useful life or lease term.",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "accountingstandardsupdateextensiblelist": "http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member",
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionexplanation": "Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. ",
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "12 months",
    "cashandcashequivalentsfairvaluedisclosure": 232017000,
    "clinicalmanufacturingandscientificdevelopmentcurrent": 2820000,
    "prepaidinsurance": 850000,
    "otherassetscurrent": 629000,
    "propertyplantandequipmentgross": 3513000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1074000,
    "employeerelatedliabilitiescurrent": 2809000,
    "accruedresearchanddevelopmentexpensescurrent": 2489000,
    "accruedprofessionalfeescurrent": 530000,
    "otherliabilitiescurrent": 26000,
    "contractwithcustomerliabilityrevenuerecognized": 31000000,
    "contractwithcustomerliability": 24800000,
    "preferredstockvotingrights": "The holders of outstanding shares of Preferred Stock shall be entitled to elect three directors of the Company. The investors have agreed that two of the directors are to be named by one investor and the other director is to be named by a separate investor.",
    "temporaryequitynoncumulativedividend": 0.08,
    "preferredstockconvertibleconversionratio": 1,
    "percentageofholdersofoutstandingsharesofpreferredstock": 0.75,
    "commonstockvotingrights": "The holders of shares of common stock are entitled to one vote for each share of common stock held at all meetings of stockholders and written action in lieu of meetings; there is no cumulative voting. The holders of outstanding shares of common stock shall be entitled to elect two directors of the Company.",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "stockoptioncontractualterm": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 19100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 346613,
    "increaseinnumberofsharesreservedandavailableforissuanceaspercentageoncommonstockoutstanding": 0.01,
    "allocatedsharebasedcompensationexpense": 5177000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 48522,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.17,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.73,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 7.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 33275000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 33275000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 16928000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0068000000000000005,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.013300000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.6858,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.733,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.07400000000000001,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.006999999999999999,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.005,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.05,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.322,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 18233000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 5269000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 6385000,
    "deferredtaxassetscapitallosscarryforwards": 242000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 629000,
    "deferredtaxassetsdeferredincome": 6769000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1026000,
    "deferredtaxassetsleaseliability": 1908000,
    "deferredtaxassetsgross": 40461000,
    "deferredtaxliabilitiespropertyplantandequipment": 648000,
    "deferredtaxliabilitiesleasingarrangements": 1786000,
    "deferredincometaxliabilities": 2434000,
    "deferredtaxassetsvaluationallowance": 38027000,
    "valuationallowancedeferredtaxassetchangeinamount": 11000000,
    "operatinglosscarryforwards": 83400000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 1700000,
    "taxcreditcarryforwardexpirationbeginmonthandyear": "December 2031",
    "opentaxyear": 2021,
    "royaltiesterms": " The Company will pay the AskAt royalties a percentage in the low single digits as defined in the AskAt License on any commercialized product sales related to the licensed technology.",
    "operatingleaseliability": 6987000,
    "operatingleasecost": 1693000,
    "variableleasecost": 479000,
    "leasecost": 2172000,
    "operatingleasepayments": 1259000,
    "lesseeoperatingleaseremainingleaseterm": 4.4,
    "lesseeoperatingleasediscountrate": 0.077,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1774000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1827000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1882000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1938000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 817000,
    "lesseeoperatingleaseliabilitypaymentsdue": 8238000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1251000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 233000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  }
]